Ticker
NKTRCompany Name
NEKTAR THERAPEUTICSSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Inventory | Inventory to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 207.53M | $ 0 | 0% |
3/31/2025 | $ 256.24M | $ 0 | 0% |
12/31/2024 | $ 303.85M | $ 0 | 0% |
9/30/2024 | $ 307.97M | $ 0 | 0% |
6/30/2024 | $ 343.33M | $ 14.46M | 4.21% |
3/31/2024 | $ 396.01M | $ 16.24M | 4.1% |
12/31/2023 | $ 398.03M | $ 16.1M | 4.05% |
9/30/2023 | $ 442.24M | $ 15.13M | 3.42% |
6/30/2023 | $ 494.28M | $ 20.69M | 4.19% |
3/31/2023 | $ 561.74M | $ 20.23M | 3.6% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Inventory / Assets
(=) Inv. to Assets
Inv. to Assets for NEKTAR THERAPEUTICS is calculated as follows: Inventory [ $ 12.89M ] / Assets [ $ 1.51B ]
(=) Inv. to Assets [ 0.85% ]
Minimum
Sep 30, 2024
Maximum
Jun 30, 2024
Average
Median
filtered constituents | 4.46K |
---|---|
min | 0% |
max | 98.39% |
average | 6.08% |
median | 0% |
std | 11.11% |